| Package | dk.kip.rkkp.fhir.ig.core |
| Resource Type | ValueSet |
| Id | TreatmentRegimen |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-TreatmentRegimen.html |
| URL | https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen |
| Version | 2.12.0 |
| Status | active |
| Date | 2022-07-13T00:00:00+02:00 |
| Name | TreatmentRegimen |
| Title | Behandlingsplan |
| Description | Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling |
No resources found
| CodeSystem | |
| TreatmentRegimen | Treatment regimen |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet TreatmentRegimen
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen| Code | Display | Definition |
| hydrea | Hydrea | Hydrea |
| hdara_c | HdAraC | Hd-Ara-c +- supplement |
| da31087 | DA inkl. 3+10, 3+8, 3+7 | DA inkl. 3+10, 3+8, 3+7 |
| da31087my | DA inkl. 3+10, 3+8, 3+7 + mylotarg | DA inkl. 3+10, 3+8, 3+7 + mylotarg |
| da31087mi | DA inkl. 3+10, 3+8, 3+7 + midostaurin | DA inkl. 3+10, 3+8, 3+7 + midostaurin |
| flagmito | FLAG-Ida eller lign inkl FLAG, Mito-FLAG | FLAG-Ida eller lign inkl FLAG, Mito-FLAG |
| flagmitovene | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax |
| idarac | IdAraC | IdAraC |
| apl_mt | APL vedligehold | APL-vedligeholdsbehandling |
| azacitidinmono | Azacitidin monoterapi | Azacitidin monoterapi |
| blinatumomab | Blinatumunab | Blinatumomab |
| vyxeos | Vyxeos | Vyxeos +- supplement |
| nopho_2008 | NOPHO 2008 | NOPHO-2008 |
| atoatra | ATO+ATRA | ATO+ATRA |
| aida | AIDA | AIDA |
| azacitidinvene | Azacitidin-venetoclax | Azacitidin-venetoclax |
| toplusfem | 2+5 eller lign, eks. CT | 2+5 eller lign, eks. CT |
| gilteritinib | Gilteritinib | Gilteritinib |
| midostaurin_ved | Midostaurin vedligehold | Midostaurin vedligehold |
| inotuzumab | Inotuzumab ozogamicin | Inotuzumab ozogamicin |
| all_ved | ALL vedligehold | ALL vedligehold |
| hyper_cvad | Hyper-CVAD | Hyper-CVAD |
| alltogether_mt | ALLtogether | ALLtogether |
| other_ikke | Anden ikke-intensiv | Anden ikke-intensiv |
| other_eks | Anden eksperimentel | Anden eksperimentel |
| other_semi | Anden semiintensiv (f.eks. Plan B) | Anden semiintensiv (f.eks. Plan B) |
| other_int | Anden intensiv (f.eks. BISHOP, Plan A) | Anden intensiv (f.eks. BISHOP, Plan A) |
{
"resourceType": "ValueSet",
"id": "TreatmentRegimen",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen",
"version": "2.12.0",
"name": "TreatmentRegimen",
"title": "Behandlingsplan",
"status": "active",
"experimental": true,
"date": "2022-07-13T00:00:00+02:00",
"publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact": [
{
"name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom": [
{
"system": "url",
"value": "https://trifork.com"
},
{
"system": "email",
"value": "rbk@trifork.com"
}
]
}
],
"description": "Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling",
"compose": {
"include": [
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen",
"concept": [
{
"code": "hydrea",
"display": "Hydrea"
},
{
"code": "hdara_c",
"display": "HdAraC"
},
{
"code": "da31087",
"display": "DA inkl. 3+10, 3+8, 3+7"
},
{
"code": "da31087my",
"display": "DA inkl. 3+10, 3+8, 3+7 + mylotarg"
},
{
"code": "da31087mi",
"display": "DA inkl. 3+10, 3+8, 3+7 + midostaurin"
},
{
"code": "flagmito",
"display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG"
},
{
"code": "flagmitovene",
"display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"
},
{
"code": "idarac",
"display": "IdAraC"
},
{
"code": "apl_mt",
"display": "APL vedligehold"
},
{
"code": "azacitidinmono",
"display": "Azacitidin monoterapi"
},
{
"code": "blinatumomab",
"display": "Blinatumunab"
},
{
"code": "vyxeos",
"display": "Vyxeos"
},
{
"code": "nopho_2008",
"display": "NOPHO 2008"
},
{
"code": "atoatra",
"display": "ATO+ATRA"
},
{
"code": "aida",
"display": "AIDA"
},
{
"code": "azacitidinvene",
"display": "Azacitidin-venetoclax"
},
{
"code": "toplusfem",
"display": "2+5 eller lign, eks. CT"
},
{
"code": "gilteritinib",
"display": "Gilteritinib"
},
{
"code": "midostaurin_ved",
"display": "Midostaurin vedligehold"
},
{
"code": "inotuzumab",
"display": "Inotuzumab ozogamicin"
},
{
"code": "all_ved",
"display": "ALL vedligehold"
},
{
"code": "hyper_cvad",
"display": "Hyper-CVAD"
},
{
"code": "alltogether_mt",
"display": "ALLtogether"
},
{
"code": "other_ikke",
"display": "Anden ikke-intensiv"
},
{
"code": "other_eks",
"display": "Anden eksperimentel"
},
{
"code": "other_semi",
"display": "Anden semiintensiv (f.eks. Plan B)"
},
{
"code": "other_int",
"display": "Anden intensiv (f.eks. BISHOP, Plan A)"
}
]
}
]
}
}